IPP Bureau
Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market
By IPP Bureau - April 08, 2023
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada
By IPP Bureau - April 08, 2023
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
By IPP Bureau - April 08, 2023
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
Todaro Robotics completes 2+ years partnership with Abwiz Bio
By IPP Bureau - April 07, 2023
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA
By IPP Bureau - April 07, 2023
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma
Zydus receives final approval from the USFDA for Carbidopa and Levodopa Tablets
By IPP Bureau - April 07, 2023
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Zydus receives final approval from the USFDA for Acetazolamide Tablets
By IPP Bureau - April 07, 2023
Acetazolamide is used to treat glaucoma
Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO
By IPP Bureau - April 06, 2023
Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023
Approx 800 million Indians do not have health coverage, says Expert
By IPP Bureau - April 06, 2023
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
Bridgewest Group launches new sterile injectable CDMO NovaCina
By IPP Bureau - April 06, 2023
Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections
By IPP Bureau - April 06, 2023
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product
By IPP Bureau - April 06, 2023
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting
By IPP Bureau - April 05, 2023
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
SK Capital completes acquisition of Apotex
By IPP Bureau - April 05, 2023
